Benefit of perioperative chemotherapy in the patients with loco-regional recurrence of HR-positive HER2-negative breast cancer: A multi-institutional retrospective cohort study.

Authors

Yukinori Ozaki

Yukinori Ozaki

Breast Medical Oncology Department, Cancer Institute Hospital of the Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan

Yukinori Ozaki , Emi Tokuda , Fumikata Hara , Shinsuke Sasada , Yasuaki Sagara , Masataka Sawaki , Chizuko Kanbayashi , Takashi Yamanaka , Tatsuya Onishi , Yoshitaka Fujiki , Akihiko Suto , Yuko Takahashi , Eriko Tokunaga , Tomoyuki Aruga , Rikiya Nakamura , Tomomi Fujisawa , Shigehira Saji , Hiroji Iwata , Tadahiko Shien

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 526)

DOI

10.1200/JCO.2024.42.16_suppl.526

Abstract #

526

Poster Bd #

118

Abstract Disclosures